Myriad Uranium Announces Closing of C$8.6 Million Bought Deal LIFE Private Placement

Executive Summary

• Myriad Uranium Corp. closed a bought‑deal private placement for gross proceeds of C$8,603,000, including the exercise of the underwriters’ over‑allotment option.
• The offering consisted of 21,507,500 units at C$0.40 per unit; each unit includes one common share and one common‑share purchase warrant (exercisable at C$0.60).
• Net proceeds will be used to fund exploration and advancement of the Copper Mountain Uranium Project (Wyoming) and Red Basin Project (New Mexico), as well as for general corporate purposes and working capital.

Key Details

• Units sold: 21,507,500 units @ C$0.40 per unit → Gross proceeds: C$8,603,000.
• Unit composition: 1 common share + 1 warrant (right to purchase one additional common share at C$0.60).
• Warrant term: exercisable any time from Jan 13 2026 to Nov 13 2028.
• Underwriters: Red Cloud Securities Inc. (lead underwriter & sole bookrunner) and Research Capital Corporation; received cash fees of C$475,680 plus 1,189,200 non‑transferable broker warrants.
• Broker Warrants: each convertible into one common share at the offering price; subject to a hold period ending Mar 14 2026 if exercised before that date.
• Use of proceeds: exploration and development of Copper Mountain Uranium Project (Wyoming) and Red Basin Project (New Mexico); also for general corporate purposes and working capital.
• Related‑party participation: Directors/officers purchased 181,250 units for C$72,500; transaction exempt from MI 61‑101 valuation/approval thresholds.
• Regulatory notes: Offering subject to final approval by the Canadian Securities Exchange (CSE); securities not registered in the U.S. and cannot be offered there.

Notable Quotes

(No direct quotes were provided in the release.)